Greenwich LifeSciences, Inc. (GLSI) Financials

GLSI Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 10.5 million 5.2 million
Dec. 31, 2025 -6.7 million 2.0 million
Sept. 30, 2025 3.8 million 1.6 million
June 30, 2025 3.1 million 1.7 million

GLSI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -4.7 million 1.5 million
Dec. 31, 2025 -3.2 million 2.2 million
Sept. 30, 2025 -2.7 million 1.5 million
June 30, 2025 -2.2 million 1.5 million

GLSI Net Income

No data available :(

GLSI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 10.5 million - -
Dec. 31, 2025 -6.7 million - -
Sept. 30, 2025 3.8 million - -
June 30, 2025 3.1 million - -

GLSI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 14.6 million
Dec. 31, 2025 14.3 million
Sept. 30, 2025 13.6 million
June 30, 2025 13.4 million

GLSI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 3 5.2 million 518190 -
Dec. 31, 2025 3 3.5 million 653066 -
Sept. 30, 2025 7 3.5 million 653066 -
June 30, 2025 3 3.5 million 538047 -

GLSI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 3558 1779
Dec. 31, 2025 3558 1779
Sept. 30, 2025 - -
June 30, 2025 - 876

GLSI

Price: $24.06

52 week price:
7.78
34.10

Earnings Per Share: -1.61 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 30476

Market Capitalization: 326.6 million

Links: